|

The 22st Annual
The “Official“ Ironman Sports Medicine Conference
October 3-7, 2010
held in conjunction with the
Ford Ironman Triathlon World Championship
Royal Kona Resort, Kailua-Kona
Big Island of Hawaii
Course Information and Accreditation
COURSE OVERVIEW
The purpose of this course is to present cutting edge information in the areas of sports medicine, exercise science and common sports related injury and illness that family physicians can directly apply to the care of their active and athletic patients. At the conclusion of the course, participants will be invited to apply lessons learned to the care of athletes competing in the Ironman World Triathlon Championships as volunteers in the Ironman Medical tent. They will be allowed to volunteer for 4 hours in the tent under the direct supervision of the Ironman Conference Faculty. This 4-hour "mini-internship" allows the participant to see hands on application of the material learned in the course.
COURSE OBJECTIVES
- Describe recent advances regarding various medical problems and their impact on the athlete and exercise performance.
- Identify current recommendations for proper nutrition in active and athletic patients.
- Illustrate key skills in the diagnosis and management of common musculoskeletal problems encountered by family physicians.
- Diagnose common problems encountered by endurance athletes and effectively treat these conditions.
- Define common medical-legal issues relevant to the sports medicine physician.
AAFP CME Credit
This activity has been reviewed and is acceptable for up to 25.00 Prescribe credits by the American Academy of Family Physicians.
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 CreditTM toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed credit, not as Category 1.
FACULTY DISCLOSURE
The Ironman Sports Medicine Conference requires that faculty participating in the CME Activities disclose to the audience any relationship with a pharmaceutical or industrial concern that might pose a potential, apparent, or real conflict of interest with regard to each faculty’s contribution to the program.
|